Tab Mapper
The tab mapper is a handy little tool that will render a guitar tab file with graphic chord diagrams displayed alongside. This comes in handy for people who just don't have every single chord shape memorized. Just plug in the web site address of a valid .tab or .crd file and hit "Go". In general, the tab mapper does a better job with printer friendly URLs. If there is more than one way to play a chord, the tab mapper will choose the most common shape. To see other fingerings, click on the chord diagram and you will be taken to the chord calculator.
Original file located @ http://e-cep.org.
Show me scales that sound good with the chords in this song: A, D, Do.
- Home
- Sitemap
- Contact Us
- TOPICS
- Adolescence Medicine
- Allergy
- Cardiology
- Critical Care Medicine
- Developmental and Behavioral Medicine
- Emergency Medicine
- Endocrinology
- Gastroenterology
- General Pediatrics
- Genetics and Metabolism
- Hematology
Browse all articles >
- Infection
- Neonatology (Perinatology)
- Nephrology (Genitourinary)
- Neurology
- Nutrition
- Oncology
- Neurobehavior
- Pulmonology
- Rheumatology
- Other
- ARTICLE CATEGORY
- Perspective
- Review article
- Systematic review and meta-analysis
- Editorial
- Present Perspective on the Past Research
- Original article
- Letter to the editor
- Clinical note
- Case report
- Others
Browse all articles >
- BROWSE ARTICLES
- Current issue
- All issues
- Accepted articles
- Ahead-of print
- Most viewed
- Most downloaded
- Most cited
- Funded articles
- Search
- Author index
- FOR CONTRIBUTORS
- Instructions for authors
- Research and publication ethics
- Instructions for peer reviewers
- Author?s checklist
- Best article award
- Best reviewer award
- E-submission
- Copyright transfer agreement
- ABOUT
- Aims and scope
- About the journal
- Editorial board
- Best practice
- Open access
- Subscription information
- Contact us
-
Search
| Article 68(12); Dec 2025 |
Review Article Oncology Breaking the barrier: a guidelines-based review of antiangiogenesis drug resistance in pediatric cancer therapy Nader Shakibazad, Mahdi Shahriari, Mani Ramzi Clin Exp Pediatr. 2025;68(12):952-962. Published online November 24, 2025
| Antiangiogenic therapy resistance in pediatric cancers involves alternative angiogenic pathways, microenvironmental support, hypoxia-driven signaling, metabolic reprogramming, and structural adaptations such as vascular co-option. Metabolic adaptation highlights tumor plasticity. Effective treatments combine immunotherapy with biomarkers. To address vascular endothelial growth factor limitations, emerging targets include hypoxia-inducible factor-2?, endoglin, CXCR4, angiopoietin/Tie2, and bispecific antibodies. In resource-constrained settings, the guidelines recommend low-dose chemotherapy plus oral multiantiangiogenic agents to ensure improved accessibility and treatment outcomes. |
DOI: https://doi.org/10.3345/cep.2025.01809
- Full text
- PubReader
- ePub
Nutrition Exploring nutritional screening tools for hospitalized children: a narrative review Pankaj Soni, Amit Agrawal, Gaurav Jadon Clin Exp Pediatr. 2025;68(12):963-970. Published online October 22, 2025
| Malnutrition is frequently identified in hospitalized children, and the use of nutritional screening tools is crucial for assessing their nutritional status during their hospital admission and stay. Common tools include the Pediatric Yorkhill Malnutrition Score, Screening Tool for Assessment of Malnutrition in Pediatrics, and Screening Tool for Risk of Nutritional Status and Growth. However, these tools have varying sensitivities and specificities, and none is recommended for all hospitalized children. |
DOI: https://doi.org/10.3345/cep.2025.00633
- Full text
- PubReader
- ePub
Editorial Infection Beyond COVID-19: meeting the challenge of evolving pediatric invasive group A streptococcal disease Han Wool Kim Clin Exp Pediatr. 2025;68(12):971-973. Published online November 26, 2025
| Pediatric for invasive group A Streptococcus has resurged globally with increasing severity and toxin-mediated presentations. Beta-lactams remain the first-line treatment, but linezolid has emerged as a safe alternative in cases refractory to ?-lactams. Early intravenous immunoglobulin use may improve outcomes in severe streptococcal toxic shock syndrome cases, while C-reactive protein and procalcitonin aid early risk stratification. Integrating global surveillance and individualized therapy is crucial in the postpandemic era. |
DOI: https://doi.org/10.3345/cep.2025.02600
- Full text
- PubReader
- ePub
Original Article Oncology HLA?B*58:01 and skin reactions in pediatric hematology and oncology patients treated with allopurinol Parisa Maneechai, Cholada Ratanatharathron, Jassada Buaboonam, Kleebsabai Sanpakit Clin Exp Pediatr. 2025;68(12):974-980. Published online October 2, 2025
Crossref 1
| Question: Does human leukocyte antigen (HLA)?B*58:01 increase the risk of cutaneous reactions in pediatric patients with hematological and oncological diseases receiving allopurinol? Finding: : Of 108 patients, 17.6% carried HLA?B*58:01 but none developed skin reactions. The only rash occurred in an HLA-B*58:01?negative patient. Meaning: Short-duration allopurinol may mitigate severe cutaneous adverse reaction risk regardless of genotype. Routine HLA-B*58:01 screening may be unnecessary in pediatric patients with hematological and oncological diseases briefly receiving allopurinol. |
DOI: https://doi.org/10.3345/cep.2025.01032
- Full text
- PubReader
- ePub
Hematology Assessment of natural killer cell subpopulations in pediatric patients with transfusion-dependent ?-thalassemia major Fathia Ibrahim Elbassal, Mohamed Abdel Rehim Soliman, Nourhan Hossam Eldin Mohamed, Mai El-Sayad Abd El-Hamid, Hanan Hassan El-Sheity Clin Exp Pediatr. 2025;68(12):981-990. Published online September 12, 2025
| Question: How does iron overload affect immunity in pediatric patients with transfusion-dependent ?-thalassemia major? Finding: Iron overload in these patients is associated with disrupted natural killer (NK) cell subpopulations, reflecting impaired innate immunity. Meaning: This highlights the need to monitor immune profile alongside iron status during thalassemia management. |
DOI: https://doi.org/10.3345/cep.2025.01046
- Full text
- PubReader
- ePub
Neonatology (Perinatology) Less invasive surfactant administration versus intubation-surfactant-extubation: a single-center retrospective study C.S. Jithin, A. Nalina, A. Shashidhar, P.N. Suman Rao Clin Exp Pediatr. 2025;68(12):991-997. Published online October 2, 2025
| Question: Does less invasive surfactant administration (LISA) (vs. intubation-surfactant-extubation) improve clinical outcomes in preterm infants with respiratory distress syndrome? Finding: LISA significantly reduced intubation and invasive mechanical ventilation needs within the first 72 hours and shortened the overall invasive respiratory support duration without increasing other morbidities. Meaning: LISA is a less invasive and safer surfactant delivery alternative. Larger multicenter trials are needed to confirm its long-term safety and efficacy, especially in low- and middle-income countries. |
DOI: https://doi.org/10.3345/cep.2025.00332
- Full text
- PubReader
- ePub
Infection Association between vitamin D polymorphisms and binding protein and COVID-19 risk and severity in children Victoria Giatraki, Helen Dimitriou, Georgia Martimianaki, Christos Tsatsanis, Emmanouil Galanakis, Chrysoula Perdikogianni Clin Exp Pediatr. 2025;68(12):998-1006. Published online October 22, 2025
| Question: Addressing crucial genetic variants within the vitamin D pathway and coronavirus disease 2019 (COVID-19) susceptibility, the vitamin D receptor, vitamin D binding protein, and CYP27B1-1260 polmorphisms might be associated with COVID-19 occurrence and severity in children. Finding: The FokI FF genotype might be an independent risk factor for COVID-19 severity in childhood. Meaning: This research may further elucidate genetic susceptibility to multisystem viral infections and establish genetic markers for severe clinical outcomes. |
DOI: https://doi.org/10.3345/cep.2025.00577
- Full text
- PubReader
- ePub
Clinical outcomes and healthcare utilization of hospitalized children with influenza versus COVID-19 David Chun-Ern Ng, Chuin-Hen Liew, Kah Kee Tan, Joanne Pereira, Muhammad Ihsan Roslan, Xiang Lin Cheng, Hui Yi Lim, Farah Nuruliayana A. Nazri, Asuwani Maran, Wan Fei Wong, Yasothai Chandran, Syaniza Shaharudin, Pon Ling Lau, Naveen Nair Gangadaran, Marlindawati Mohd Ali Clin Exp Pediatr. 2025;68(12):1007-1014. Published online October 2, 2025
| Question: How do clinical presentations, healthcare resource utilization, and outcomes differ between children hospitalized with influenza versus coronavirus disease 2019 (COVID-19)? Finding: Patients with influenza were older, were more symptomatic, and required greater healthcare resources, including intravenous fluids, empirical antibiotics, respiratory support, and pediatric intensive care unit admission. Meaning: Influenza involves greater severity and a higher healthcare burden than COVID-19, highlighting the need for preventive strategies such as vaccination and hospital resource planning during seasonal outbreaks. |
DOI: https://doi.org/10.3345/cep.2025.00759
- Full text
- PubReader
- ePub
Critical Care Medicine Cytokine profile of Post?cardiopulmonary bypass in children Kantara Saelim, Kanokpan Ruangnapa, Jirayut Jarutach, Pongsanae Duangpakdee, Smonrapat Surasombatpattana, Pharsai prasertsan Clin Exp Pediatr. 2025;68(12):1015-1022. Published online September 19, 2025
| Question: Can cytokine levels predict low cardiac output syndrome (LCOS) in children post?cardiopulmonary bypass? Finding: Elevated interleukin (IL)-6, IL-8, and tumor necrosis factor-? levels were associated with LCOS, with an increase in IL-8 of >56 pg/mL from baseline to immediately postoperative being the strongest predictor. Meaning: Monitoring immediately postoperative IL-8 levels may help identify pediatric patients at risk of LCOS, enabling timely interventions to improve outcomes. |
DOI: https://doi.org/10.3345/cep.2025.00836
- Full text
- PubReader
- ePub
Pulmonology Ciclesonide shows a lung-protective effect in neonatal hyperoxia-exposed rats Victoria Mielgo, Miguel A. Gomez-Solaetxe, Lara Olazar, Begoña Loureiro, Carmen Rey-Santano Clin Exp Pediatr. 2025;68(12):1023-1030. Published online October 2, 2025
| Question: Bronchopulmonary dysplasia (BPD) is the most prevalent chronic lung disease of prematurity. Numerous nonpharmacological/pharmacological interventions have been investigated without clear consensus. Can ciclesonide, a new synthetic glucocorticoid, effectively treat BPD? Finding: Ciclesonide mitigated hyperoxia-induced lung injury and right ventricular hypertrophy in newborn rats. Meaning: These findings suggest that postnatal ciclesonide may be an alternative to existing corticosteroids for the treatment of BPD. |
DOI: https://doi.org/10.3345/cep.2025.01137
- Full text
- PubReader
- ePub
General Pediatrics Lipoprotein(a) prevalence trends in Portuguese children and adolescents: a real-world perspective Isabel Morais Ribeiro, Susete Vieira, Miguel Saraiva, Mónica Tavares, José Carlos Oliveira, Isabel Mangas Palma, Helena Ferreira Mansilha Clin Exp Pediatr. 2025;68(12):1031-1040. Published online November 24, 2025
| Early lipid screening, including lipoprotein(a) (Lp(a)), in children/adolescents is key to identifying and managing dyslipidemia and reducing the risk of early-onset cardiovascular disease. This study shows that prevalence of elevated Lp(a) in high-risk Portuguese children is alarming, with over 30% at intermediate/high risk and nearly 1% at very high-risk (>430 nmol/L). Since Lp(a) is mostly genetically determined, one-time early screening in atrisk children is crucial for timely monitoring and prevention. |
DOI: https://doi.org/10.3345/cep.2025.00339
- Full text
- PubReader
- ePub
Clinical Note Gastroenterology Successful rescue after catastrophic bleeding of carotid artery pseudoaneurysm following button battery ingestion in a toddler Manjit Kaur, Ujjal Poddar, Basant Kumar, Abdul Muzil Munshi, Rajanikant R. Yadav, Moinak Sen Sarma, Anshu Srivastava Clin Exp Pediatr. 2025;68(12):1041-1044. Published online October 22, 2025
| Button battery (BB) ingestion is an increasing hazard. Catastrophic gastrointestinal bleeding due to pseudoaneurysm rupture following BB impaction is often fatal. Here we report the case of an unwitnessed BB ingestion in an 18-month-old boy who presented with repeated massive UGIB due to a left CCA pseudoaneurysm that was successfully managed multidisciplinarily. BB ingestion should be considered in toddlers presenting with hematemesis. |
DOI: https://doi.org/10.3345/cep.2025.01347
- Full text
- PubReader
- ePub
-
6.02024CiteScore98th percentilePowered by
-
Impact Factor3.6
- MOST CITED ACCEPTED ARTICLES
Cited By
35Neurodevelopmental outcomes of preterm infants Cited By
31Long COVID in children and adolescents: prevalence, clinical manifestations, and management strategies Cited By
30Prevalence of anxiety, depression, and stress among parents of neonates admitted to neonatal intensive care unit: a systematic review and meta-analysis Cited By
29Gut microbiota affects brain development and behavior Cited By
28Association of gut microbiota with obesity in children and adolescents +more
External tracheal compression and mucosal injury in a neonate with cervical teratoma: a rare airway challenge Progression from acute to chronic pancreatitis in children: a systematic review and meta-analysis Sacral dimple: clinical perspectives of lesions hidden beneath the skin Discordance between antibiotic therapy and recurrent urinary tract infections in young children with thirdgeneration cephalosporin-resistant infections Comparing ethyl chloride and 10% lignocaine spray for pediatric intravenous cannulation pain relief +more
TOPICS
- Adolescence Medicine
- Allergy
- Cardiology
- Critical Care Medicine
- Developmental and Behavioral Medicine
- Emergency Medicine
- Endocrinology
- Gastroenterology
- General Pediatrics
- Genetics and Metabolism
- Hematology
Browse all articles >
- Infection
- Neonatology (Perinatology)
- Nephrology (Genitourinary)
- Neurology
- Nutrition
- Oncology
- Neurobehavior
- Pulmonology
- Rheumatology
- Other
- Perspective
- Review article
- Systematic review and meta-analysis
- Editorial
- Present Perspective on the Past Research
- Original article
- Letter to the editor
- Clinical note
- Case report
- Others
Browse all articles >
BROWSE ARTICLES- Current issue
- All issues
- Accepted articles
- Ahead-of print
- Most viewed
- Most downloaded
- Most cited
- Funded articles
- Search
- Author index
- Instructions for authors
- Research and publication ethics
- Instructions for peer reviewers
- Author?s checklist
- Best article award
- Best reviewer award
- E-submission
- Copyright transfer agreement
- Aims and scope
- About the journal
- Editorial board
- Best practice
- Open access
- Subscription information
- Contact us
Editorial Office Korean Pediatric Society
#1606 Seocho World Officetel, 19 Seoun-ro, Seocho-ku, Seoul 06732, Korea
Tel: +82-2-3473-7306 Fax: +82-2-3473-7307 E-mail: office@e-cep.org
#1606 Seocho World Officetel, 19 Seoun-ro, Seocho-ku, Seoul 06732, Korea
Tel: +82-2-3473-7306 Fax: +82-2-3473-7307 E-mail: office@e-cep.org
Clinical and Experimental Pediatrics is an open access journal. All articles are distributed under the terms of the Creative Commons Attribution NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/)
Copyright © 2025 by Korean Pediatric Society.
Award Announcement (2025)
We are pleased to announce the recipients of the 2025 Best Article and Best Reviewer Awards.
? Best Article Award
? Best Reviewer Award
Thank you for your continued support and contribution to our journal.
Do not open this window today [Close]
©2025 JGuitar.com